| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
92,870 |
86,094 |
$7.91M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
72,700 |
66,935 |
$5.56M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
32,049 |
30,095 |
$2.70M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
23,098 |
21,700 |
$2.15M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
45,876 |
38,800 |
$708K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
82,163 |
35,787 |
$389K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
37,196 |
32,028 |
$181K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
29,539 |
27,146 |
$142K |
| 99215 |
Prolong outpt/office vis |
1,012 |
980 |
$98K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,321 |
4,178 |
$97K |
| 99051 |
|
24,849 |
21,670 |
$66K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,184 |
2,686 |
$51K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
466 |
437 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,476 |
10,974 |
$30K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
240 |
218 |
$14K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
124 |
120 |
$11K |
| 81003 |
|
10,945 |
9,367 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
36 |
35 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,323 |
6,557 |
$3K |
| 87807 |
|
1,062 |
994 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
985 |
886 |
$1K |
| 81025 |
|
2,804 |
2,567 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
53 |
48 |
$480.10 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
334 |
277 |
$110.70 |
| 99000 |
|
1,427 |
1,274 |
$24.88 |
| 82962 |
|
219 |
200 |
$5.40 |
| A9150 |
Non-prescription drugs |
1,716 |
1,457 |
$0.50 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
321 |
278 |
$0.48 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
114 |
114 |
$0.00 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
165 |
156 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
22 |
12 |
$0.00 |
| 86308 |
|
18 |
16 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$0.00 |
| 73130 |
|
12 |
12 |
$0.00 |
| 73610 |
|
178 |
172 |
$0.00 |
| 73630 |
|
105 |
103 |
$0.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
126 |
126 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
13 |
13 |
$0.00 |